washingtonpost.com
The trial in 10 countries in Latin America and Europe will continue, and a final result is not expected until the end of June. The CureVac vaccine is of key importance to Europe, which has preordered 225 million doses.
over 4 years ago
washingtonpost.com
David Julius at the University of California at San Francisco and Ardem Patapoutian at Scripps Research share the award.
about 4 years ago
washingtonpost.com
The review of the Johnson & Johnson vaccine suggests the Food and Drug
Administration sees a clearer need for another dose of that shot than for other
coronavirus vaccines.
about 4 years ago
washingtonpost.com
The protective effect was so convincing that an independent panel monitoring a
trial of the drug advised it be stopped early.
about 4 years ago
washingtonpost.com
The study suggests a second booster may not yet be necessary.
almost 4 years ago
washingtonpost.com
The FDA announced that the fall shots would include a component from BA.4 and
BA.5, the omicron subvariants gaining ground in the United States.
over 3 years ago
washingtonpost.com
Questions persist about the vaccine’s continued effectiveness against a swarm of later-generation versions of omicron.
about 3 years ago
washingtonpost.com
The shot increased the levels of antibodies that block the latest coronavirus subvariant.
about 3 years ago
washingtonpost.com
Scientists are unraveling the secrets of mummification – including the intriguing discovery that the practice may have been dependent on a global supply chain.
almost 3 years ago
washingtonpost.com
To unravel how malaria-carrying mosquitoes sniff out their next juicy meal, scientists set up a screened-in outdoor laboratory in Zambia.
over 2 years ago
washingtonpost.com
To unravel how malaria-carrying mosquitoes sniff out their next juicy meal, scientists set up a screened-in outdoor laboratory in Zambia.
over 2 years ago